Skip to main content
Figure 2 | BMC Medicine

Figure 2

From: Human papillomavirus vaccine introduction in low-income and middle-income countries: guidance on the use of cost-effectiveness models

Figure 2

Incremental cost-effectiveness ratios for vaccination from each model. Discounted incremental cost-effectiveness ratios for vaccination in the hypothetical low-income (top graph) and middle-income (bottom graph) countries, using each of the six models. Dotted lines show gross domestic product (GDP) per capita for the hypothetical country. Missing bars indicate that results were not available for that model.

Back to article page

BMC Medicine

ISSN: 1741-7015

Contact us